Press Release | Thu Jul 11, 2013 7:30am EDT

FDA Accepts Eliquis® (apixaban) Supplemental New Drug Application for Review for Prophylaxis of Deep Vein Thrombosis Following Hip Or Knee Replacement Surgery

* Reuters is not responsible for the content in this press release.